Skip to main content

Research Repository

Advanced Search

Discovery of new imidazotetrazinones with potential to overcome tumor resistance

Summers, Helen S.; Lewis, William; Williams, Huw E. L.; Bradshaw, Tracey D.; Moody, Christopher J.; Stevens, Malcolm F. G.

Discovery of new imidazotetrazinones with potential to overcome tumor resistance Thumbnail


Authors

Helen S. Summers

William Lewis

Christopher J. Moody

Malcolm F. G. Stevens



Abstract

We describe the design, organic synthesis, and characterization, including X-ray crystallography, of a series of novel analogues of the clinically used antitumor agent temozolomide, together with their in vitro biological evaluation. The work has resulted in the discovery of a new series of anticancer imidazotetrazines that offer the potential to overcome the resistance mounted by tumors against temozolomide. The rationally designed compounds that incorporate a propargyl alkylating moiety and a thiazole ring as isosteric replacement for a carboxamide, are readily synthesized (gram-scale), exhibit defined solid-state structures, and enhanced growth-inhibitory activity against human tumor cell lines, including MGMT-expressing and MMR-deficient lines, molecular features that confer tumor resistance. The cell proliferation data were confirmed by clonogenic cell survival assays, and DNA flow cytometry analysis was undertaken to determine the effects of new analogues on cell cycle progression. Detailed 1H NMR spectroscopic studies showed that the new agents are stable in solution, and confirmed their mechanism of action. The propargyl and thiazole substituents significantly improve potency and physicochemical, drug metabolism and permeability properties, suggesting that the thiazole 13 should be prioritized for further preclinical evaluation.

Citation

Summers, H. S., Lewis, W., Williams, H. E. L., Bradshaw, T. D., Moody, C. J., & Stevens, M. F. G. (2023). Discovery of new imidazotetrazinones with potential to overcome tumor resistance. European Journal of Medicinal Chemistry, 257, Article 115507. https://doi.org/10.1016/j.ejmech.2023.115507

Journal Article Type Article
Acceptance Date May 18, 2023
Online Publication Date May 30, 2023
Publication Date Sep 5, 2023
Deposit Date May 22, 2023
Publicly Available Date Jun 7, 2023
Journal European Journal of Medicinal Chemistry
Print ISSN 0223-5234
Electronic ISSN 1768-3254
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 257
Article Number 115507
DOI https://doi.org/10.1016/j.ejmech.2023.115507
Keywords Organic Chemistry; Drug Discovery; Pharmacology; General Medicine
Public URL https://nottingham-repository.worktribe.com/output/21100715
Publisher URL https://www.sciencedirect.com/science/article/pii/S0223523423004737?via%3Dihub

Files





You might also like



Downloadable Citations